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INTRODUCTION
The epithelial—mesenchymal transition (EMT) 
is an impactful cell behavior in normal and disease 
states in metazoans (Yang et al., 2020). Cell move-
ments that are a product of EMT during embryonic 
development are essential to form numerous tissues 
and organs via mechanisms that are analogous to 
cell invasion during cancer metastasis (Acloque et 
al., 2009; Hutchins et al., 2018; Kerosuo and Bron-
ner-Fraser, 2012; Theveneau and Mayor, 2012; 
Thiery et al., 2009). The EMT program is dynamic 
and requires rapid molecular transitions to achieve 
a spectrum of intermediate cell states that imbue 
cells with different degrees of plasticity, reversibili-
ty, invasion, and migration (Aiello et al., 2018; Nie-
to et al., 2016; Pastushenko and Blanpain, 2019). 
The neural crest is a classic example of an essen-
tial developmental cell type that undergoes a tightly 
regulated EMT driven by changing molecular signa-
tures that alter their migratory ability, and ultimately 
cell fate choice (Gouignard et al., 2018; Martik and 
Bronner, 2017). These intrinsic cellular changes are 
driven by sequential activation of gene regulatory 
networks (Fazilaty et al., 2019; Williams et al., 2019), 
the outputs of which are subsequently fine-tuned via 
post-transcriptional regulatory mechanisms (Bhat-
tacharya et al., 2018; Weiner, 2018). 
In both development and disease, post-transcrip-
tional regulation and, in particular, RNA turnover are 
key mechanisms by which cells are able to quickly 
alter their transcriptomic landscape and transit be-
tween cell states (Chen and Shyu, 2017; Hardy et al., 
2017; Lou et al., 2015). The process of RNA decay is 
highly conserved across eukaryotes and mediated by 
multiple mRNA turnover pathways (Parker and Song, 
2004). One of the major eukaryotic mRNA decay 
pathways is Xrn1-mediated, which occurs 5’→3’ as 
opposed to 3’→5’ exosome-mediated decay (Muhl-
rad et al., 1995; Siwaszek et al., 2014). Xrn1-medi-
ated decay was originally demonstrated in yeast to 
occur within discrete cytoplasmic foci called process-
ing bodies (P-bodies) (Sheth and Parker, 2003). In-
terestingly, P-body formation is necessary for EMT in 
cancer cells; disrupting P-bodies blocked metastasis 
and caused the cells to retain more epithelial char-
acteristics (Hardy et al., 2017). However, which tran-
scripts localize to P-bodies during EMT or how they 
are processed to drive mesenchymal characteristics 
remain unknown. Recent work in human cell lines 
has suggested that metazoan Xrn1-mediated decay 
may occur broadly within the cytosol, with P-bod-
The epithelial—mesenchymal transition (EMT) drives cellular movements during development to 
create specialized tissues and structures in metazoans, using mechanisms often coopted during 
metastasis. Neural crest cells are a multipotent stem cell population that undergo a developmentally 
regulated EMT and are prone to metastasis in the adult, providing an excellent model to study cell state 
changes and mechanisms underlying EMT. A hallmark of neural crest EMT during avian development 
is temporally restricted expression followed by rapid down-regulation of the Wnt antagonist Draxin. 
Using live RNA imaging, here we demonstrate that rapid clearance of Draxin transcripts is mediated 
post-transcriptionally via localization to processing bodies (P-bodies), small cytoplasmic granules 
which are established sites of RNA processing. Contrasting with recent work in immortalized cell 
lines suggesting that P-bodies are sites of storage rather than degradation, we show that targeted 
decay of Draxin occurs within P-bodies during neural crest migration. Furthermore, P-body disruption 
via DDX6 knockdown inhibits not only endogenous Draxin down-regulation but also neural crest EMT 
in vivo. Together, our data highlight a novel and important role for P-bodies in an intact organismal 
context—controlling a developmental EMT program via post-transcriptional target degradation.
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2ies serving as sites of translational repression and 
storage rather than decay (Horvathova et al., 2017; 
Hubstenberger et al., 2017), though this has been 
shown to vary based on target and context (Aizer et 
al., 2014). Thus, the role of P-bodies during EMT as 
sites of storage versus decay remains controversial.
Here, we describe a critical role for P-body-medi-
ated RNA decay in control of an essential vertebrate 
developmental EMT program—onset of neural crest 
cell migration. Using adapted live RNA imaging tools, 
we show that transcripts encoding Draxin, a molecu-
lar rheostat controlling neural crest EMT, are targeted 
to and decayed within P-bodies in neural crest cells 
via a DDX6-dependent mechanism.
RESULTS
An EMT rheostat is regulated via RNA decay
Cranial neural crest EMT in the chick embryo is 
spatiotemporally controlled by transient attenuation 
of canonical Wnt signaling (Hutchins and Bronner, 
2018, 2019; Maj et al., 2016; Rabadán et al., 2016). 
A major regulator of this damping of Wnt signaling 
is the secreted protein, Draxin, which is expressed 
in a brief pulse to modulate gene expression output 
for proper timing of cranial neural crest EMT. A hall-
mark of Draxin function in this process is the rapid 
down-regulation of its mRNA, coincident with onset 
of the EMT program (Fig. 1A-B); this clearance of 
transcript is essential for cranial neural crest cells 
to achieve a mesenchymalized state during EMT 
(Hutchins and Bronner, 2018, 2019). Using in situ 
hybridization chain reaction (HCR), a highly sensi-
tive method that allows visualization of single mRNA 
transcripts with subcellular localization, we examined 
Draxin mRNA following cranial neural crest EMT. The 
results reveal low levels of Draxin mRNA localized to 
discrete cytoplasmic granules, which did not colocal-
ize with AP2β mRNA, a transcript highly expressed in 
migratory neural crest (Simoes-Costa and Bronner, 
2016) (Fig. 1C-D). The granular appearance of Drax-
in mRNA coincident with its rapid downregulation led 
to the intriguing hypothesis that Draxin may be tar-
geted to cytoplasmic granules for decay (Anderson 
and Kedersha, 2009) to facilitate EMT. 
To explore this possibility, we next investigated 
whether the localization and down-regulation of Drax-
in accompanying EMT is mediated by cellular RNA 
decay pathways leading to targeted degradation of 
transcript. To this end, we designed an in vivo fluo-
rescent reporter construct to first determine whether 
Draxin is post-transcriptionally regulated via its 3’-un-
translated region (UTR) within living embryos. The 3’-
UTR is a major determinant of mRNA stability, owing 
to cis regulatory sequences (e.g. AU-rich elements) 
contained therein (Garneau et al., 2007; Grzybows-
ka et al., 2001; Guhaniyogi and Brewer, 2001). We 
electroporated gastrula stage chick embryos (Ham-
burger-Hamilton stage HH4 (Hamburger and Hamil-
ton, 1951)) with reporter constructs driving ubiquitous 
expression of destabilized EGFP (d2EGFP), followed 
Figure 1. The EMT rheostat Draxin is post-transcriptionally regulated. 
(A-D), Representative confocal maximum intensity projection micrographs of HCR processed wild type embryos for Draxin and AP2β 
transcripts in whole mount (A-B) and section (C-D). Mander’s coefficients (M1 and M2) were calculated to determine overlap of expression 
between Draxin and AP2β in migratory neural crest. 
(E) Experimental design to examine Draxin’s post-transcriptional regulation using UTR-reporter constructs. 
(F-G) Representative epifluorescence images of embryos expressing UTR-reporter constructs and immunostained for neural crest marker 
Pax7. HH, Hamburger-Hamilton stage; M, Mander’s coefficient; UTR, untranslated region. Scale bars, 20 μm (A-C,F-G) and 1 μm (D). Error 
bars, SEM.
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3by either a control 3’-UTR (β-globin), which gener-
ates a stable and highly translated transcript (Lodish 
and Small, 1976; Wilson and Deeley, 1995), or the 
endogenous Draxin 3’-UTR (Fig. 1E). The results 
revealed d2EGFP expression in premigratory neural 
crest cells from both constructs. Interestingly, at the 
migratory stage, only the control 3’-UTR construct 
displayed robust d2EGFP expression; in contrast, 
expression from the Draxin 3’-UTR construct was 
drastically diminished, consistent with the timing of 
endogenous Draxin down-regulation (Fig. 1F-G). To-
gether, these data suggest a post-transcriptional reg-
ulatory mechanism for Draxin down-regulation during 
cranial neural crest EMT, mediated via its 3’-UTR.
Draxin targets to P-bodies during EMT
To understand the dynamics of Draxin’s post-tran-
scriptional regulation during EMT in living cells, we 
adapted the improved, degradable MS2-MCP report-
er system (Tutucci et al., 2018) to visualize the con-
trol (β-globin) and Draxin 3’-UTR-containing RNAs 
by time-lapse imaging. We electroporated early gas-
trula stage embryos with YFP-tagged, nuclear MS2 
coat protein (MCP) in conjunction with a modified 
MS2 stem loop (24xMBSV6) construct containing ei-
ther the β-globin or Draxin 3’-UTR, thus allowing us 
to infer subcellular localization and stability of tran-
script based on fluorescence signal intensity from 
MCP within the cytoplasm. At neurula stages, the 
cranial neural folds were explanted to enable visual-
ization within emigrating and migrating neural crest 
cells (Fig. 2A). As expected for the control UTR-con-
taining construct (MS2-β-globin-UTR), MCP-bound 
transcripts formed large (≥ 2μm diameter) cytoplas-
mic granules that were intensely bright and stably 
fluorescent during cranial neural crest cell migration 
(Fig. 2B-C). Importantly, the Draxin 3’-UTR-contain-
ing construct (MS2-Draxin-UTR) in contrast localized 
to small (< 1μm diameter) cytoplasmic granules that 
Figure 2. Draxin localizes to P-bodies during neural crest EMT. 
(A) Experimental design to visualize transcript dynamics in migrating neural crest cells. 
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4degraded within 2 h (Fig. 2B-C; P < 0.001, Kolm-
ogorov-Smirnov nonparametric test). Treatment with 
the translation inhibitor cycloheximide, which stabiliz-
es ribosomes bound to RNA and dissolves P-bodies 
(Aizer et al., 2008), had no effect on the large control 
granules, suggesting these were transcripts associ-
ated with ribosomes and likely sites of active trans-
lation (Supplementary Fig. S1A); notably, however, 
we saw a decrease in the number of MS2-Draxin-
UTR granules (Supplementary Fig. S1B), suggest-
ing these transcripts may be localizing to P-bodies for 
decay during neural crest EMT.
To determine if the Draxin 3’-UTR localizes to 
P-bodies during cranial neural crest EMT, we first 
asked whether known P-body components are ex-
pressed in these cells. Using HCR in situ hybridiza-
tion, we observed enrichment of P-body-associated 
transcripts (e.g., DCP1a, XRN1, DDX6/p54) (Decker 
and Parker, 2012) in premigratory and migratory cra-
nial neural crest cells as well as neural tissues (Sup-
plementary Fig. S2). Given that neural crest cells 
have the necessary components to form P-bodies, we 
next asked whether the MS2-Draxin-UTR transcripts 
colocalized with any P-body proteins in migrating 
crest cells. As commercial antibodies for these pro-
teins failed to work with chick tissue, we co-electro-
porated a construct expressing human DCP1a fused 
to the far-red fluorescent protein FP635 (FP-DCP1a) 
with YFP-tagged MCP and MS2-Draxin-UTR and an-
alyzed fixed cranial neural crest explants; the results 
showed that MS2-Draxin-UTR transcripts significant-
ly associated with FP-DCP1a puncta (Fig. 2D-F; P 
< 0.001, Kolmogorov-Smirnov nonparametric test), 
confirming the results inferred by MCP localization. 
To further validate the localization of MS2-Draxin-
UTR transcripts to P-bodies, we used CRISPR/Cas9 
to knockdown the RNA helicase DDX6 (Supplemen-
tary Fig. S3; 69.4 ± 3.0% of the control, P < 0.001, 
two-tailed paired t-test), which has been shown to be 
required for P-body formation (Andrei et al., 2005; 
Standart and Weil, 2018). Importantly, DDX6 knock-
down drastically altered the subcellular localization of 
MS2-Draxin-UTR transcripts (Fig. 2G-I; P = 0.018, 
Kolmogorov-Smirnov nonparametric test). Together, 
these data suggest that a DDX6-dependent mech-
anism recruits Draxin transcripts via its 3’-UTR to 
P-bodies during EMT, and these are likely sites of 
RNA decay in cranial neural crest.
RNA decays within P-bodies during neural 
crest EMT
Use of the MS2/MCP reporter system in neural 
crest explants allowed us to infer that a critical reg-
ulator of EMT—Draxin—localizes to P-bodies and 
is subsequently degraded (Fig. 2). However, recent 
data from cell lines has suggested that P-bodies 
may act as sites of storage rather than decay; based 
on the absence of degradation intermediates within 
P-bodies, as assayed using either fluorescence ac-
tivated particle sorting (FAPS) with RNA-sequencing 
(Hubstenberger et al., 2017) or a two-color MS2/PP7 
stem loop-based reporter system (TREAT) (Horva-
thova et al., 2017), previous investigators hypothe-
sized that degradation within these immortalized cell 
lines occurs within the cytosol rather than in P-bod-
ies. To distinguish between these possibilities in the 
context of neural crest EMT, we adapted the two-col-
or TREAT reporter assay to the neural crest system 
to determine whether Draxin transcripts are degrad-
ed within P-bodies or the cytosol.
To this end, we modified our MS2-Draxin-UTR 
construct that utilized the recently improved MS2 
stem loop (Tutucci et al., 2018) (Fig. 2) to include the 
Xrn1-resistant pseudoknots (xrRNA) and PP7 stem 
loops from the TREAT reporter downstream (3’) of 
the MS2 loop region (MS2-xrRNA-PP7-Draxin-UTR). 
In this way, Xrn1-mediated decay should occur in a 
5’→3’ direction, degrading the MS2/MCP-GFP fluo-
rescent signal, but will be blocked by the xrRNA pseu-
doknots, leaving the PP7/PCP-mCherry signal intact. 
Therefore, sites of decay should accumulate singly 
fluorescent PP7/PCP-mCherry degradation interme-
diates. As a control, we used a construct lacking the 
(B-C) Normalized fluorescence intensity measurements (B) of MCP-labeled cytoplasmic granules, determined from confocal time lapse (C) 
of neural crest cells explanted from embryos co-electroporated with YFP-tagged, nuclear MCP and either MS2-β-globin-UTR or MS2-Draxin-
UTR (10 min intervals). MS2-containing transcripts are visualized by MCP fluorescence, pseudocolored using a lookup table (LUT) to highlight 
differences in fluorescence intensity (LUT calibration indicated on left). 
(D-E) Representative confocal maximum intensity projection micrograph of MS2-Draxin-UTR transcripts, indicated by MCP fluorescence, 
colocalized with the fluorescently-tagged P-body marker DCP1a (FP-DCP1a) in an explanted neural crest cell. 
(F) Mander’s coefficient (M1) was calculated to determine the extent of colocalization; 90° rotation of MCP images were compared to unrotated 
FP-DCP1a images as a control (M190). 
(G-H) Representative epifluorescence images of explanted neural crest cells expressing MS2-Draxin-UTR transcripts, indicated by MCP 
fluorescence, co-electroporated with Cas9 and either control gRNA or DDX6 gRNA constructs (indicated by H2B-RFP fluorescence). 
(I) Intensity profiles were calculated as normalized gray values across the cytoplasm. Dotted arrows in (G-H) indicate example intensity profile 
measurements. HH, Hamburger-Hamilton stage; MCP, MS2 coat protein; M, Mander’s coefficient; UTR, untranslated region. Scale bars, 1 
μm. Error bars, SEM. *, P < 0.02, Kolmogorov-Smirnov test. 
See also Supplemental Figures S1-S3.
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5xrRNA pseudoknots (MS2-PP7-Draxin-UTR), which 
should not accumulate singly fluorescent degrada-
tion intermediates (Fig. 3A). This follows the original 
logic of the TREAT reporter system and helps deter-
mine to what extent (if any) the PP7/PCP-mCherry 
complex may artificially stabilize transcripts.
The results show that the pseudoknot-contain-
ing construct (MS2-xrRNA-PP7-Draxin-UTR) yields 
significant enrichment of singly fluorescent PP7/
PCP-mCherry degradation intermediates overlap-
ping with the P-body marker (FP-DCP1a) (Fig. 3B-D; 
P < 0.001, two-tailed t-test, n = 128 P-bodies), an 
indication of 5’→3’ decay. Furthermore, using time 
lapse live imaging, we observed degradation of the 
MS2/MCP-GFP fluorescent signal while the PP7/
PCP-mCherry signal remained intact within a single 
P-body (Supplemental Fig. S4). 
In contrast, the control construct lacking the xr-
RNA pseudoknot (MS2-PP7-Draxin-UTR), failed to 
yield significant differences (Fig. 3B; P = 0.51, two-
tailed t-test, n = 60 P-bodies) between singly- or 
dual-fluorescent MCP/PCP signals within P-bodies, 
suggesting that the PP7 stem loops in complex with 
PCP-mCherry may partially inhibit Xrn1-mediated de-
cay, at least in the neural crest. These results suggest 
that use and positioning of PP7 stem loops in report-
er constructs to assess decay in relation to P-bodies 
should be carefully considered based on context. Im-
portantly however, we observed significant differenc-
es for the singly fluorescent PP7/PCP-mCherry (P = 
0.01, two-tailed t-test), as well as the dual-fluorescent 
MCP/PCP signals (P < 0.01, two-tailed t-test), with 
the presence of the xrRNA pseudoknot compared 
to its absence (Fig. 3B). Thus, while the PP7 stem 
loops may minimally interfere with transcript decay 
in our system, positioning these loops downstream 
of the MS2 and xrRNA loops still allowed detection 
of 5’→3’ decay. From these data, we propose that 
Xrn1-mediated decay of Draxin occurs within P-bod-
ies in cranial neural crest.
Figure 3. Targeted Draxin decay occurs within P-bodies. 
(A) Schematic diagram of expected fluorescence results using a modified TREAT reporter containing the Draxin 3’UTR to localize Xrn1-
mediated transcript decay. 
(B) Normalized percentage of P-bodies containing singly fluorescent MCP granules, singly fluorescent PCP granules, or dual-fluorescent 
MCP/PCP granules, for neural crest cells expressing the modified TREAT reporter with/without the xrRNA pseudoknot. 
(C-D) Representative epifluorescence images of dual labeled (MCP+PCP) or single labeled (PCP only) P-bodies in neural crest cells 
expressing the modified TREAT reporter. MCP, MS2 coat protein; PCP, PP7 coat protein; UTR, untranslated region. Scale bars, 1 μm. Error 
bars, SEM.  *, P ≤ 0.01, two-tailed t-test. 
See also Supplemental Figure S4.
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 1, 2020. . https://doi.org/10.1101/2020.07.31.231860doi: bioRxiv preprint 
6P-body disruption blocks cranial neural 
crest EMT in vivo
Use of an artificial reporter system in neural crest 
explants allowed us to infer that degradation of a crit-
ical regulator of EMT—Draxin—occurs within P-bod-
ies (Fig. 3), and that P-body localization of the Draxin 
3’-UTR requires DDX6 (Fig. 2). We next asked what 
happens to endogenous Draxin in intact chick em-
bryos when DDX6 is knocked down. Using HCR, we 
observed perdurance of endogenous Draxin (Fig. 
4A-C; 113.8 ± 2.5% of the control side, P < 0.001, 
two-tailed paired t-test, n = 8 embryos), which is nor-
mally downregulated during neural crest EMT (Fig. 
1). Importantly, we found that neural crest EMT was 
inhibited by loss of DDX6 (Fig. 4D; 86.4 ± 2.7% of the 
control side, P < 0.001, two-tailed paired t-test, n = 15 
embryos), which phenocopies the effects of aberrant-
ly maintaining Draxin expression during EMT beyond 
when it should have been endogenously downregu-
lated (Hutchins and Bronner, 2018). This is consis-
tent with observations in human patients with DDX6 
mutations, who display defects in P-body assembly 
and often present with craniofacial abnormalities 
(Balak et al., 2019), a hallmark of cranial neural crest 
dysfunction (Vega-Lopez et al., 2018). Together, our 
data highlight a critical role for DDX6 in the control 
of cranial neural crest EMT and provide evidence for 
Xrn1-mediated decay within P-bodies of a biological-
ly relevant target with an important developmental 
function.
DISCUSSION
There is a growing appreciation for the role of 
post-transcriptional regulation in the control of EMT, 
particularly in the neural crest. Much of our under-
standing of the control of EMT has come through 
careful dissection of gene regulatory networks and 
transcription-dependent cellular changes during 
development and disease (Aiello and Kang, 2019; 
Aiello et al., 2018; Nieto et al., 2016; Yang et al., 
2020). Recent studies have suggested that the tran-
scriptional networks controlling EMT are titrated 
post-transcriptionally via microRNA-mediated re-
pression (Bhattacharya et al., 2018; Cursons et al., 
2018; Sanchez-Vasquez et al., 2019; Weiner, 2018). 
Translational repression or transcript degradation 
via microRNAs effect subtle adjustments on network 
Figure 4. P-bodies are integral to Draxin decay and neural crest EMT. 
(A-B) Representative confocal maximum intensity projection micrographs of HCR processed embryos for endogenous Draxin and AP2β 
transcripts in whole mount embryos bilaterally electroporated with constructs encoding Cas9 and control gRNA (left) or DDX6 gRNA (right). 
Draxin transcripts are pseudocolored using a lookup table (LUT) to highlight differences in fluorescence intensity (LUT calibration indicated 
on right). 
(C) Relative fluorescence intensity of Draxin for DDX6 knockdown compared to control sides of individual embryos. 
(D) Representative confocal maximum intensity projection micrographs of HCR processed embryos for AP2β transcripts in whole mount 
embryos with DDX6 knockdown, used to calculate the area of neural crest migration (blue outline). Normalized area measurements compared 
the AP2β expression domain for DDX6 knockdown compared to control sides of individual embryos. (E) Model depicting the role of P-bodies 
in mediating Draxin decay to control neural crest EMT. HH, Hamburger-Hamilton stage; KO, CRISPR/Cas9 knockout; pNC, premigratory 
neural crest; mNC, migratory neural crest; NT, neural tube. Scale bars, 20 μm. *, P < 0.001, paired t-test. 
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gene expression (Bartel, 2018). In stark contrast, 
we demonstrate here that full and rapid transcript 
clearance of a molecular rheostat is essential for 
controlling EMT. Our work further provides the first 
demonstration in metazoans that this targeted mRNA 
decay occurs within P-bodies during EMT (Fig. 4E).
But why invoke multiple modes of post-transcrip-
tional repression to control EMT? The fine-tuning 
of expression levels by microRNAs is important in 
light of recent paradigm shifts in our understanding 
of EMT—that cells often display partial EMT pheno-
types that are highly dynamic, existing on a sliding 
scale between “epithelial” or “mesenchymal” states 
(Nieto et al., 2016; Yang et al., 2020). How does this 
fit with full-scale RNA clearance within P-bodies? In 
the neural crest, Draxin expression acts like a throttle 
for EMT; once that throttle is removed via P-body-me-
diated decay, and EMT initiates, we hypothesize a 
shift to microRNA-mediated repression to influence 
the spectrum of EMT cell states required for the 
neural crest to acquire more mesenchymal charac-
teristics and initiate migration. During development, 
one can imagine similar scenarios directing cell fate 
choices—whereby dynamic and reversible repres-
sion by microRNAs may drive cell fate specification, 
but cell fate commitment may require transcript clear-
ance by P-bodies. 
For microRNA-independent transcript decay, 
RNA-binding proteins (RBPs) likely mediate tran-
script localization to P-bodies in neural crest. RBPs 
recognize cis elements within RNA transcripts, par-
ticularly in 3’-UTRs, to direct mRNA subcellular local-
ization, translational regulation, or decay (Gebauer et 
al., 2012). In addition, RBP function and localization 
is often controlled through post-translational modifi-
cations as a result of upstream signaling pathways 
(Schoenberg and Maquat, 2012). Given that many 
developmental processes, including neural crest 
specification and EMT, are downstream of signaling 
events, RBPs offer a mode of coordination of extra-
cellular signals with transcript regulation leading to 
cell state changes. Understanding the balance of 
transcript stability versus decay, and the mechanisms 
mediating these choices, will yield valuable insight 
into the control EMT, as well as cell fate decisions, 
during development and disease.
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9METHODS
Model organism and embryo collection
Fertilized chicken eggs (Gallus gallus) were obtained 
commercially (Sunstate Ranch, Sylmar, CA). Eggs 
were incubated at 37°C to reach specified Ham-
burger-Hamilton (HH) stage (Hamburger and Ham-
ilton, 1951). Embryos were collected from eggs us-
ing Whatman filter paper as described (Hutchins and 
Bronner, 2018), and processed as indicated below. 
Hybridization chain reaction, 
immunohistochemistry, and sectioning
Hybridization chain reaction v3.0 (HCR; Molecular 
Technologies) was performed according to manu-
facturer’s instructions (Choi et al., 2018) with cus-
tom HCR probe sets and Alexa488, Alexa546, and 
Alexa647 HCR amplifiers. Immunohistochemistry 
was performed for Pax7 as previously described 
(Hutchins and Bronner, 2018). Cross-sections were 
cryosectioned at 20 μm using previously published 
protocols (Hutchins and Bronner, 2018, 2019).
Electroporations and neural crest explants
Electroporations were performed on HH4 gastru-
la stage chicken embryos as described previously 
(Hutchins and Bronner, 2018, 2019). Embryos elec-
troporated with reagents for CRISPR/Cas9 were in-
cubated at 37°C for 4 hours immediately following 
electroporation, then the incubator was shut off for 
6 hours to allow CRISPR reagents time to function; 
incubation at 37°C was then resumed for 8-10 hours 
to reach the desired HH stage. For all other electro-
porations, embryos were continuously incubated at 
37°C immediately following electroporation until the 
desired HH stage was reached.
Neural crest explants were generated as described 
(Manohar et al., 2020; Rogers et al., 2013), with mi-
nor modification. Briefly, dorsal neural tubes from 5-6 
somite stage (HH8+/HH9-) embryos were dissected 
in Ringer’s solution. Tissue was then transferred to 
1% fibronectin-coated chambered slides (μ-Slide 8 
Well Glass Bottom, Ibidi #80827, for live imaging; 
Nunc™ Lab-Tek™ II Chamber Slide with removable 
wells, Thermo #154534, for fixed imaging), contain-
ing DMEM media supplemented with 10% FBS, 2 mM 
L-glutamine, and 100 U penicillin/0.1 mg/mL strepto-
mycin. Explants were grown 12-18 hours at 37°C/5% 
CO2, then directly imaged (time lapse experiments) or 
fixed with 4% paraformaldehyde for 20 min at room 
temperature. For explants treated with cycloheximide 
(CHX), CHX (Sigma #C4859) was added to media 
following overnight incubation to a final concentration 
of 100 μg/mL; explants were incubated at 37°C/5% 
CO2 for 1 hour, then washed in PBS and fixed.
Constructs
Constructs were verified by sequencing prior to elec-
troporation. To generate the d2EGFP-β-globin-UTR 
reporter construct, we excised the IRES-H2B-RFP 
cassette from pCI-H2B-RFP (Betancur et al., 2010), 
which contained the β-globin-UTR downstream of 
the cassette. We PCR amplified d2EGFP from M38 
TOP-dGFP (Addgene #17114), engineering XhoI and 
NotI sites using primer sequences 5’-AAACTCGAG-
GCCACCATGGTGAGCAAGG and 5’-AAAGCGGC-
CGCCTACACATTGATCCTAGCAGAAG and cloned 
the coding region upstream of the β-globin-UTR. 
To generate the d2EGFP-Draxin-UTR reporter con-
struct, we excised the β-globin-UTR from the d2EG-
FP-β-globin-UTR reporter construct using NotI and 
PvuII sites. We cloned in place the Draxin 3’-UTR, 
which we PCR amplified from stage HH9 cDNA us-
ing primer sequences 5’-ATAGCGGCCGCGGCTAC-
GCTGTTATGCCAAATTC and 5’-ATACAGCTGCTG-
CCCCATCCTCAGGTG.
To generate MCP-NLS-2xYFP, we PCR amplified 
MCP from CYC1p-MCP-NLS-2xyeGFP (Tutucci et 
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migration. Developmental biology 366, 34-54.
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zoa. Proceedings of the National Academy of Sciences of the United 
States of America 106, 21591-21596.
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Vega-Lopez, G.A., Cerrizuela, S., Tribulo, C., and Aybar, M.J. (2018). 
Neurocristopathies: New insights 150 years after the neural crest dis-
covery. Developmental biology.
Weiner, A.M.J. (2018). MicroRNAs and the neural crest: From induction 
to differentiation. Mechanisms of development 154, 98-106.
Williams, R.M., Candido-Ferreira, I., Repapi, E., Gavriouchkina, D., 
Senanayake, U., Ling, I.T.C., Telenius, J., Taylor, S., Hughes, J., and 
Sauka-Spengler, T. (2019). Reconstruction of the Global Neural Crest 
Gene Regulatory Network In Vivo. Developmental cell 51, 255-276 
e257.
Wilson, G.M., and Deeley, R.G. (1995). An episomal expression vector 
system for monitoring sequence-specific effects on mRNA stability in 
human cell lines. Plasmid 33, 198-207.
Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., 
Campbell, K., Cano, A., Casanova, J., Christofori, G., et al. (2020). 
Guidelines and definitions for research on epithelial-mesenchymal tran-
sition. Nat Rev Mol Cell Biol.
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 1, 2020. . https://doi.org/10.1101/2020.07.31.231860doi: bioRxiv preprint 
10
al., 2018) (Addgene #104394) using primer sequenc-
es 5’-GAATTGCTCGAGGCCACCATGGCTTCTA-
ACTTTACTCAGTTCG and 5’-CTCCGGCATCTAC-
CCAAAAAAAAAAAGAAAAGTTATCGATATGG, and 
cloned into the multiple cloning site of pCI-H2B-RFP 
using engineered XhoI and ClaI sites. We then ex-
cised the IRES-H2B-RFP cassette and cloned in 
place a 5’ copy of YFP lacking a stop codon, which 
we PCR amplified from IRES-H2B-YFP-DD (Han et 
al., 2014) (Addgene #96893) using primer sequenc-
es 5’-AAGTTATCGATATGGTGAGCAAGGGCGAGG 
and 5’-GCATGGACGAGCTGTACAAGAGCGGC-
CGCATGGT. We then PCR amplified a 3’ copy of YFP 
with a stop codon using primer sequences 5’-CAA-
GAGCGGCCGCATGGTGAGCAAGGG CGAGG and 
5’-GGACGAGCTGTACAAGTAAGCGGCCGCAAT-
TC and cloned downstream of the first YFP. To gen-
erate MCP-NLS-2xGFP, we PCR amplified 2xEGFP 
from phage UbiC NLS HA stdPCP stdGFP (Horva-
thova et al., 2017) (Addgene #104099) using primer 
sequences 5’-TCTATCGATATGGTGAGCAAGGG-
CGAG and 5’-ATAGCGGCCGCTTATTTGTACAAT-
TCATCCATACCATGGG, and cloned in place of 
2xYFP. To generate PCP-NLS-2xmCherry, we PCR 
amplified PCP from phage UbiC NLS HA stdPCP st-
dGFP (Horvathova et al., 2017) (Addgene #104099) 
using primer sequences 5’-ATACTCGAGCGCCAC-
CATGGGCCCAAA and 5’-CTCATCGATGGTGGC-
GACCGGTGGAC, and cloned into MCP-NLS-2xYFP 
in place of MCP. We then excised 2xmCherry from 
pDZ585 pKAN 2x-mCherry (Saroufim et al., 2015) 
(Addgene # 72236) and blunt cloned the cassette in 
frame in place of 2xYFP.
To generate the MS2 stem loop constructs, we 
first PCR amplified the coding region of mTurq2 
from pME Turqoise2 (Oehlers et al., 2015) (Ad-
dgene #135207) using primer sequences 5’-ATG-
GTGAGCAAGGGCGAGGAGC and 5’-ATTGCGG-
CCGCTTACTTGTACAGCTCG and cloned into the 
d2EGFP-β-globin-UTR and d2EGFP-Draxin-UTR 
reporter constructs in place of d2EGFP. We next ex-
cised the 24xMBSV6 stem loops from pET264-pUC 
24xMS2V6 Loxp KANr Loxp (Tutucci et al., 2018) 
(Addgene #104393) and cloned upstream of the 
β-globin- and Draxin-UTRs using ClaI and NotI sites. 
To generate the modified TREAT reporter constructs, 
we first PCR amplified humanized Renilla luciferase 
from the original TREAT plasmid (Horvathova et al., 
2017) (Addgene #104096) using primer sequences 
5’-ATACTCGAGCGACTCACTATAGGCTAGCCAC 
and 5’-ATAGGCCGGCCTTACTGCTCGTTCTTCAG-
CAC, and cloned in place of mTurq2 in the MS2-
Draxin-UTR construct. We then inserted artificial se-
quence containing unique restriction sites between 
the 24xMBSV6 stem loops and Draxin 3’-UTR to 
facilitate cloning. We excised the PP7 stem loops 
from the original TREAT plasmid and blunt cloned 
between the 24xMBSV6 stem loops and Draxin 3’-
UTR to generate the Luc-MS2-PP7-Draxin-UTR 
control construct. We then PCR amplified the xrR-
NA pseudoknots from the original TREAT plasmid 
using primer sequences 5’-CGCATCGATGCGTA-
AGTCAGGCCGGAAA and 5’-GTGACGCGTGTAG-
GTAGGATCCTCACCCAGTCC, and cloned into 
the Luc-MS2-PP7-Draxin-UTR control construct be-
tween the 24xMBSV6 stem loops and the PP7 stem 
loops, to generate the Luc-MS2-xrRNA-PP7-Draxin-
UTR construct.
To generate the FP-DCP1a construct, we PCR 
amplified the coding region of the far-red fluores-
cent protein turboFP635 (Evrogen) using primer 
sequences 5’-TGTACCGGTCTCGAGGCCACCAT-
GGTGGGTGAGG and 5’-AGATCCGGAGCTGTG-
CCCCAGTTTGCTA, and cloned in place of EGFP 
in pT7-EGFP-C1-HsDCP1a (Tritschler et al., 2009) 
(Addgene # 25030). We then excised the FP635-DC-
P1a cassette and blunt cloned into d2EGFP-β-glo-
bin-UTR in place of the d2EGFP coding region.
For CRISPR/Cas9 experiments, plasmids encoding 
Cas9, Cas9-GFP, and control gRNA were described 
previously (Gandhi and Bronner, 2018; Gandhi et 
al., 2017). The DDX6 gRNA plasmid was generat-
ed by cloning a protospacer sequence (5’-AGATC-
GAGAATTCTTCCAG), designed using CHOPCHOP 
(Labun et al., 2019), into the modified gRNA back-
bone (Gandhi et al., 2017). For electroporations with 
untagged Cas9, pCI-H2B-RFP was co-electroporat-
ed to infer which cells received the knockdown re-
agents, as described previously (Gandhi et al., 2017).
Image acquisition and analysis
Confocal images were acquired using an upright 
Zeiss LSM 880, an inverted Zeiss LSM 800, and/
or an inverted Zeiss LSM 710 at the Caltech Bio-
logical Imaging Facility, and epifluorescence imag-
es were acquired using a Zeiss Imager.M2 with an 
ApoTome.2 module. Time lapse experiments were 
performed using the Zeiss LSM 800 and/or the Zeiss 
LSM 710 with incubation set to 37°C/5% CO2. Imag-
es were minimally processed for brightness/contrast 
and pseudocolored using Fiji (ImageJ, NIH) and Ado-
be Photoshop 2020.
Colocalization measurements were determined by 
calculation of the Mander’s coefficients M1 and M2 
using the JaCoP (Bolte and Cordelieres, 2006) plugin 
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in Fiji. Mander’s coefficients were calculated using 
square ROIs approximately 100 μm2. For P-body M1 
measurements, ROIs were cropped around P-bodies 
to exclude nuclei. Only cells containing both FP-DC-
P1a-positive granules and MCP-positive nuclei were 
considered; within these cells, all P-bodies were mea-
sured for colocalization with cytoplasmic MCP signal. 
As a control for P-body colocalization, ROIs from 
MCP images were rotated 90° and compared to un-
rotated FP-DCP1a images to calculate the Mander’s 
coefficient (M190) to rule out nonspecific overlap by 
chance (Lee et al., 2020).
Relative area of neural crest migration was deter-
mined in Fiji. For each whole mount image, the line 
tool was used to draw an ROI surrounding the area 
of neural crest indicated by AP2β expression (exam-
ple indicated in Fig. 4D). Measurements were made 
for the control electroporated (left) and experimental 
electroporated (right) sides from the same embryo, 
and then the experimental electroporated area was 
divided by the control electroporated area to calcu-
late the relative area of neural crest migration. Rela-
tive fluorescence intensity was determined similarly 
following background subtraction (50-pixel rolling ball 
radius), using the same ROIs from area measure-
ments. Relative fluorescence intensity was then cal-
culated by dividing the integrated density measure-
ments for the experimental versus the control side of 
the same embryo. For time lapse experiments, inte-
grated density was determined for single granules, 
then normalized per granule over time by dividing 
measurements by maximum measured integrated 
density. Normalized integrated density was then av-
eraged across multiple granules per time point for 
each condition.
Statistical analysis
Statistical analyses were performed using Prism (8; 
GraphPad Software). P values are defined in the text, 
and significance was established with P < 0.05. For 
assays determining whether samples have same sta-
tistical distribution (Fig. 2), significance was assessed 
using a Kolmogorov-Smirnov nonparametric test. For 
all other assays of multiple comparisons, P values 
were calculated using two-tailed unpaired (Fig. 3) or 
paired (Fig. 4) t-tests. Data shown as bar graphs are 
presented as mean values, with error bars indicating 
SEM and individual data points shown. Data compar-
ing relative values of control versus morphant sides 
are plotted as normalized individual values with lines 
connecting values measured from the same embryo. 
Number of embryos/samples and replicates are in-
dicated in figure legends and/or text. Data were as-
sumed to be normally distributed but were not formal-
ly tested.
Data availability
All data generated and/or analyzed during the current 
study are available from the corresponding author on 
reasonable request.
Code availability
Information for accessing the JaCoP plugin used to 
calculate Mander’s coefficients is available: https://
imagej.nih.gov/ij/plugins/track/jacop.html
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Supplementary Figure S1. Cycloheximide treatment disrupted granule formation of Draxin-UTR-containing transcripts, but 
not β-globin-UTR-containing transcripts. 
(A) Representative epifluorescence images of explanted neural crest cells expressing MS2-β-globin-UTR and YFP-tagged, nuclear MCP, 
treated with 100 μg/mL CHX. 
(B) Representative epifluorescence images of explanted neural crest cells expressing MS2-Draxin-UTR and YFP-tagged, nuclear MCP, 
treated with 100 μg/mL CHX. MS2-containing transcripts are visualized by MCP fluorescence, pseudocolored using a lookup table (LUT) to 
highlight differences in fluorescence intensity (LUT calibration indicated on left). Arrowhead, presence of cytoplasmic granule. MCP, MS2 coat 
protein; CHX, cycloheximide. Scale bars, 5 μm. 
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Supplementary Figure S2. P-body components are enriched in migratory neural crest cells. 
(A-D) Representative confocal maximum intensity projection micrographs of HCR processed wild type embryos for P-body components and 
neural crest marker AP2β transcripts in whole mount (A-B) and cross-section (C-D). Boxed areas in (C-D) indicate zoomed regions in right 
panels. HH, Hamburger-Hamilton stage. Scale bars, 20 μm.
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Supplementary Figure S3. Validation of CRISPR/Cas9-mediated knockdown of DDX6. 
(A-B) Representative confocal maximum intensity projection micrographs of HCR processed embryos for DDX6 and neural crest marker 
AP2β transcripts in whole mount embryos bilaterally electroporated with constructs encoding Cas9 and control gRNA (left) or DDX6 gRNA 
(right). 
(C) Mean relative fluorescence intensity of DDX6, calculated as the ratio of normalized integrated density in DDX6 knockdown versus control 
side for individual embryos. HH, Hamburger-Hamilton stage. Scale bars, 20 μm. Error bars, SEM. *, P < 0.001, two-tailed paired t-test. 
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Supplementary Figure S4. Live RNA imaging of Draxin decay within a P-body in a migratory neural crest cell.
(A-D) Time lapse confocal micrographs of decay intermediates of MS2-xrRNA-PP7-Draxin-UTR transcripts, indicated by MCP/PCP 
fluorescence, colocalized with the fluorescently-tagged P-body marker DCP1a (FP-DCP1a) in an explanted neural crest cell. MCP, 
MS2 coat protein; PCP, PP7 coat protein. Scale bars, 1 μm. Error bars, SEM. *, P < 0.001, two-tailed paired t-test. 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted August 1, 2020. . https://doi.org/10.1101/2020.07.31.231860doi: bioRxiv preprint 
